{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:09:01Z","timestamp":1792130941414,"version":"4.4.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/ajg.2010.458","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T14:53:54Z","timestamp":1294757634000},"page":"421-431","source":"Crossref","is-referenced-by-count":88,"title":["The Effect of Dexlansoprazole MR on Nocturnal Heartburn and GERD-Related Sleep Disturbances in Patients With Symptomatic GERD"],"prefix":"10.14309","volume":"106","author":[{"given":"Ronnie","family":"Fass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Mody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen N","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy L","family":"Pilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archinte.161.1.45","article-title":"The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life.","volume":"161","author":"Farup","year":"2001","journal-title":"Arch Intern Med"},{"key":"R2-8-20210210","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","article-title":"Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.","volume":"112","author":"Locke","year":"1997","journal-title":"Gastroenterology"},{"key":"R4-8-20210210","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s10620-009-0885-2","article-title":"The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity.","volume":"55","author":"Dean","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R5-8-20210210","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cgh.2009.04.005","article-title":"Effects of gastroesophageal reflux disease on sleep and outcomes.","volume":"7","author":"Mody","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-8-20210210","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1572-0241.2003.07531.x","article-title":"Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association.","volume":"98","author":"Shaker","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R7-8-20210210","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s10620-006-9196-z","article-title":"Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study.","volume":"52","author":"Calleja","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R8-8-20210210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2036.2006.03189.x","article-title":"Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity.","volume":"25","author":"Dubois","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-8-20210210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-8986.1981.tb02921.x","article-title":"Cumulative effects of sleep restriction on daytime sleepiness.","volume":"18","author":"Carskadon","year":"1981","journal-title":"Psychophysiology"},{"key":"R10-8-20210210","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1365-2036.2003.01588.x","article-title":"The burden of illness of gastro-oesophageal reflux disease: impact on work productivity.","volume":"17","author":"Dean","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-8-20210210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1012299519637","article-title":"Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill.","volume":"10","author":"Manocchia","year":"2001","journal-title":"Qual Life Res"},{"key":"R12-8-20210210","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2036.2008.03921.x","article-title":"Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.","volume":"29","author":"Nocon","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-8-20210210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"R14-8-20210210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2036.2010.04385.x","article-title":"The development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire for adults.","volume":"32","author":"Spiegel","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-8-20210210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument.","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"R16-8-20210210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1524-4733.2002.52101.x","article-title":"Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)results from a cross-sectional study.","volume":"5","author":"Wahlqvist","year":"2002","journal-title":"Value Health"},{"key":"R17-8-20210210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00019053-200725050-00003","article-title":"The Work Productivity and Activity Impairment Questionnaire for patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation.","volume":"25","author":"Wahlqvist","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"R18-8-20210210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00044011-200323020-00001","article-title":"Lansoprazole and esomeprazole in symptomatic GERD. A double-blind, randomised, multicentre trial in 3000 patients confirms comparable symptom relief.","volume":"23","author":"Chey","year":"2003","journal-title":"Clin Drug Investig"},{"key":"R19-8-20210210","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/j.1572-0241.2003.08783.x","article-title":"Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.","volume":"98","author":"Miner","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R20-8-20210210","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1572-0241.2002.05769.x","article-title":"Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.","volume":"97","author":"Miner","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R21-8-20210210","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2036.2003.01745.x","article-title":"Once-daily pantoprazole 40mg and esomeprazole 40mg have equivalent overall efficacy in relieving GERD-related symptoms.","volume":"18","author":"Scholten","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-8-20210210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2009.04013.x","article-title":"Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease.","volume":"29","author":"Fass","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-8-20210210","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","article-title":"Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response.","volume":"32","author":"Lind","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R25-8-20210210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","article-title":"Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux diseasewhere next?","volume":"22","author":"Fass","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-8-20210210","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1572-0241.2005.00285.x","article-title":"Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.","volume":"100","author":"Johnson","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R27-8-20210210","first-page":"118","article-title":"Endpoints for the assessment of response to gastroesophageal reflux disease therapywhat are the appropriate measures of success?","volume":"4","author":"Johnson","year":"2004","journal-title":"Rev Gastroenterol Disord"},{"issue":"Suppl 4","key":"R28-8-20210210","first-page":"iv49","article-title":"Best practice in symptom assessment: a review.","volume":"53","author":"McColl","year":"2004","journal-title":"Gut"},{"key":"R29-8-20210210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0197-2456(02)00320-3","article-title":"Patient compliance with paper and electronic diaries.","volume":"24","author":"Stone","year":"2003","journal-title":"Control Clin Trials"},{"key":"R30-8-20210210","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1046\/j.1365-2036.1999.00669.x","article-title":"Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease.","volume":"13","author":"Revicki","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R31-8-20210210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7525-1-73","article-title":"Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity.","volume":"1","author":"Revicki","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R32-8-20210210","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1185\/03007990903035745","article-title":"Treatment patterns and symptom control in patients with GERD: US community-based survey.","volume":"25","author":"Chey","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R33-8-20210210","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1185\/03007990802693883","article-title":"Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials.","volume":"25","author":"Vakily","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R34-8-20210210","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2036.2009.03979.x","article-title":"Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitorevidence for dosing flexibility.","volume":"29","author":"Lee","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R35-8-20210210","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1365-2036.2010.04272.x","article-title":"The effect of time-of-day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MRevidence for dosing flexibility with a Dual Delayed Release proton pump inhibitor.","volume":"31","author":"Lee","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-8-20210210","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1365-2036.2009.04137.x","article-title":"Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience.","volume":"30","author":"Peura","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-8-20210210","first-page":"98","article-title":"Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.","volume":"8","author":"Johnson","year":"2008","journal-title":"Rev Gastroenterol Disord"},{"key":"R38-8-20210210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2036.2005.02310.x","article-title":"The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux.","volume":"21","author":"Orr","year":"2005","journal-title":"Aliment Pharmacol Ther"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2010458.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010458","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010458.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201103000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:35:22Z","timestamp":1786541722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201103000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2010.458","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}